Buck Mason and Lee just dropped some reimagined mid-century American classics — and tapped country singer Mark Wystrach to ...

Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.

The AMBUSH x UGG collection officially launched today, and if you’re thinking about snagging a pair, don’t wait too ...

Live audio webcasts will be available in the "Events and Presentations" section of Elanco's investor website . Replays will also be available for a limited time at the conclusion of each event.

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

While most tech giants have an AI voice assistant under development, one pioneer, SoundHound AI ( SOUN -1.45%) is far ahead ...

Indivior's 2025 outlook missed estimates, citing Suboxone sales erosion. The company plans $100 million in cost cuts, with ...

As Canadian markets navigate a landscape of conflicting forces, including persistent inflation and evolving leadership in various sectors, investors are keenly observing opportunities that might arise ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today reported financial results for the fourth quarter ...